BNET Industries
Market Cap:$12.3B
Last Fiscal Year Sales:$3.7B
- Public
- US
Dow Jones Description
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn., St. Jude Medical employs approximately 14,000 people worldwide and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, electrophysiology catheters, mapping and visualization systems, vascular closure devices, heart valve replacement and repair products, and neurostimulation devices.
Number of Employees 14,000
Peer Companies
NAICS Code Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
Recent Events
-
St. Jude's Stock Is No Hopeless Cause
-
St. Jude Medical Gets FDA Nod For Penta Surgical Lead To Manage Chronic Pain -...
-
SJM Releases New Neurostimulator Programming Software
-
Morgan Joseph Initiates Coverage on St. Jude Medical STJ with a Buy; High-Quality Name in...
-
UPDATE: St. Jude Leaves Trade Group AdvaMed In Tax Dispute
-
Zacks Analyst Blog Highlights: Morgan Stanley, Goldman Sachs, St.
-
Was the St. Jude sell-off overdone?
-
Canaccord Adams Downgrades St. Jude Medical Inc. STJ to Hold
-
David Moenning's Daily State of the Markets: Voting With Their Feet
-
Edwards Lifesciences Q3 Profit More Than Doubles; Updates FY09 Outlook
-
Uncertainty in face of reform
-
St. Jude Medical Announces Australian Launch of Devices that Diagnose and Treat Abnormal Heart Rhythms
-
Zacks Analyst Blog Highlights: Fannie Mae, Freddie Mac, St. Jude Medical, Medtronic and Boston...
-
Micell gets investment from St. Jude Medical
-
$15 million infusion for Micell
-
St. Jude Medical to Showcase Complete Cardiovascular Access, Intervention and Hemostasis...
-
St. Jude Medical Announces European Launch of New Version of
-
St. Jude Medical Announces European Launch of New Version of Remote Patient Care Network
News & Analysis
Filter by
board of directors and st. jude medical inc. - All News and Analysis
St. Jude Medical Elects Barbara B. Hill to Board of Directors
- 2007-12-10
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced the election of Barbara B. Hill to its board of directors, effective immediately. Ms. Hill is currently the chief executive officer and president of ValueOptions, Inc., a privately owned managed behavioral health company, where she also serves as a...
St. Jude Medical Reports First Quarter Results and Announces Plans to Expand U.S. Sales Organization; Board of Directors Authorizes $700 Million Share Repurchase Program
- 2006-04-19
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today reported sales and earnings results for the first quarter ended March 31, 2006, and announced an expansion of its selling organization in the United States. The Company also announced that its Board of Directors has authorized a new share repurchase...
St. Jude Medical Elects John W. Brown to Board of Directors
- 2005-08-04
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced the election of John W. Brown to a newly-created position on its Board of Directors, effective immediately. Mr. Brown is Chairman of the Board of Stryker Corp., a worldwide leader in orthopaedic medical devices, and served as Chief Executive...
St. Jude Medical Board of Directors Declares Two-for-One Stock Split
- 2004-10-11
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) announced today that its Board of Directors has declared a two-for-one stock split in the form of a 100% stock dividend. This marks the eighth stock split in the history of the Company.
St. Jude Medical Board of Directors Authorizes Share Repurchase
- 2004-08-16
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) announced today that its Board of Directors has authorized a share repurchase program of up to $300 million of its outstanding common stock. The authorization expires on December 31, 2006. The repurchases will occur at such times and at such prices...
St. Jude Medical Elects Merck Executive, Wendy L. Yarno, To Its Board of Directors
- 2002-02-25
Business Editors & Health/Medical Writers
- 1
Industry Transcripts by Seeking Alpha
-
Hansen Medical, Inc. Q3 2009 Earnings Call Transcript
on Dec 18, 2009about HNSN
-
Synergetics USA, Inc. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about SURG
-
Cantel Medical Corp. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 09, 2009about CMN
-
The Cooper Companies, Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about COO
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
Glass Door
St. Jude Medical
IndustryTop Rated
Presented by American Express